139 related articles for article (PubMed ID: 36656928)
21. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract][Full Text] [Related]
22. Germline
Andreotti V; Vanni I; Pastorino L; Ghiorzo P; Bruno W
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254993
[TBL] [Abstract][Full Text] [Related]
23.
Jensen MR; Jelsig AM; Gerdes AM; Hölmich LR; Kainu KH; Lorentzen HF; Hansen MH; Bak M; Johansson PA; Hayward NK; Van Overeem Hansen T; Wadt KAW
HGG Adv; 2023 Oct; 4(4):100225. PubMed ID: 37646013
[No Abstract] [Full Text] [Related]
24. Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review.
Farid M; Ngeow J
Oncologist; 2016 Aug; 21(8):1002-13. PubMed ID: 27401891
[TBL] [Abstract][Full Text] [Related]
25. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
26. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.
Würtemberger J; Ripperger T; Vokuhl C; Bauer S; Teichert-von Lüttichau I; Wardelmann E; Niemeyer CM; Kratz CP; Schlegelberger B; Hettmer S
Eur J Med Genet; 2023 May; 66(5):104718. PubMed ID: 36764384
[TBL] [Abstract][Full Text] [Related]
27. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.
Liau JY; Lee JC; Tsai JH; Yang CY; Liu TL; Ke ZL; Hsu HH; Jeng YM
Mod Pathol; 2015 Dec; 28(12):1545-54. PubMed ID: 26428317
[TBL] [Abstract][Full Text] [Related]
29. A
Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Cancer-Predisposing Germline
Jajosky AN; Mitchell AL; Akgul M; Shetty S; Yoest JM; Gerson SL; Sadri N; Oduro KA
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456397
[TBL] [Abstract][Full Text] [Related]
31. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
Wilmott JS; Johansson PA; Newell F; Waddell N; Ferguson P; Quek C; Patch AM; Nones K; Shang P; Pritchard AL; Kazakoff S; Holmes O; Leonard C; Wood S; Xu Q; Saw RPM; Spillane AJ; Stretch JR; Shannon KF; Kefford RF; Menzies AM; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA
Int J Cancer; 2019 Mar; 144(5):1049-1060. PubMed ID: 30178487
[TBL] [Abstract][Full Text] [Related]
32. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
; Haycock PC; Burgess S; Nounu A; Zheng J; Okoli GN; Bowden J; Wade KH; Timpson NJ; Evans DM; Willeit P; Aviv A; Gaunt TR; Hemani G; Mangino M; Ellis HP; Kurian KM; Pooley KA; Eeles RA; Lee JE; Fang S; Chen WV; Law MH; Bowdler LM; Iles MM; Yang Q; Worrall BB; Markus HS; Hung RJ; Amos CI; Spurdle AB; Thompson DJ; O'Mara TA; Wolpin B; Amundadottir L; Stolzenberg-Solomon R; Trichopoulou A; Onland-Moret NC; Lund E; Duell EJ; Canzian F; Severi G; Overvad K; Gunter MJ; Tumino R; Svenson U; van Rij A; Baas AF; Bown MJ; Samani NJ; van t'Hof FNG; Tromp G; Jones GT; Kuivaniemi H; Elmore JR; Johansson M; Mckay J; Scelo G; Carreras-Torres R; Gaborieau V; Brennan P; Bracci PM; Neale RE; Olson SH; Gallinger S; Li D; Petersen GM; Risch HA; Klein AP; Han J; Abnet CC; Freedman ND; Taylor PR; Maris JM; Aben KK; Kiemeney LA; Vermeulen SH; Wiencke JK; Walsh KM; Wrensch M; Rice T; Turnbull C; Litchfield K; Paternoster L; Standl M; Abecasis GR; SanGiovanni JP; Li Y; Mijatovic V; Sapkota Y; Low SK; Zondervan KT; Montgomery GW; Nyholt DR; van Heel DA; Hunt K; Arking DE; Ashar FN; Sotoodehnia N; Woo D; Rosand J; Comeau ME; Brown WM; Silverman EK; Hokanson JE; Cho MH; Hui J; Ferreira MA; Thompson PJ; Morrison AC; Felix JF; Smith NL; Christiano AM; Petukhova L; Betz RC; Fan X; Zhang X; Zhu C; Langefeld CD; Thompson SD; Wang F; Lin X; Schwartz DA; Fingerlin T; Rotter JI; Cotch MF; Jensen RA; Munz M; Dommisch H; Schaefer AS; Han F; Ollila HM; Hillary RP; Albagha O; Ralston SH; Zeng C; Zheng W; Shu XO; Reis A; Uebe S; Hüffmeier U; Kawamura Y; Otowa T; Sasaki T; Hibberd ML; Davila S; Xie G; Siminovitch K; Bei JX; Zeng YX; Försti A; Chen B; Landi S; Franke A; Fischer A; Ellinghaus D; Flores C; Noth I; Ma SF; Foo JN; Liu J; Kim JW; Cox DG; Delattre O; Mirabeau O; Skibola CF; Tang CS; Garcia-Barcelo M; Chang KP; Su WH; Chang YS; Martin NG; Gordon S; Wade TD; Lee C; Kubo M; Cha PC; Nakamura Y; Levy D; Kimura M; Hwang SJ; Hunt S; Spector T; Soranzo N; Manichaikul AW; Barr RG; Kahali B; Speliotes E; Yerges-Armstrong LM; Cheng CY; Jonas JB; Wong TY; Fogh I; Lin K; Powell JF; Rice K; Relton CL; Martin RM; Davey Smith G
JAMA Oncol; 2017 May; 3(5):636-651. PubMed ID: 28241208
[TBL] [Abstract][Full Text] [Related]
33. Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically.
Montgomery E; Argani P; Hicks JL; DeMarzo AM; Meeker AK
Am J Pathol; 2004 May; 164(5):1523-9. PubMed ID: 15111298
[TBL] [Abstract][Full Text] [Related]
34. A population-based analysis of germline BAP1 mutations in melanoma.
O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
[TBL] [Abstract][Full Text] [Related]
36. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
37. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
[TBL] [Abstract][Full Text] [Related]
38. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
39. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.
Gong Y; Stock AJ; Liu Y
Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570
[TBL] [Abstract][Full Text] [Related]
40. TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma.
Chun-On P; Hinchie AM; Beale HC; Gil Silva AA; Rush E; Sander C; Connelly CJ; Seynnaeve BKN; Kirkwood JM; Vaske OM; Greider CW; Alder JK
Science; 2022 Nov; 378(6620):664-668. PubMed ID: 36356143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
